We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Boehringer Ingelheim to Expand Drug Discovery Aggrement with Graffinity

News   Dec 14, 2006

 
Boehringer Ingelheim to Expand Drug Discovery Aggrement with Graffinity
 
 
 

RELATED ARTICLES

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

New Technology To Isolate and Pattern Cells Developed

News

Researchers have developed a novel technology that creates new opportunities for patterning cells on flat substrates.

READ MORE

3D-printed Device Finds "Needle in a Haystack" Cancer Cells by Removing the Hay

News

Finding a handful of cancer cells hiding among billions of blood cells in a patient sample can be like finding a needle in a haystack. In a new approach enabled by 3D-printed cell traps, researchers are removing the hay to expose the cancer cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE